Currency in INR
Earnings Estimate | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|
No. of Analysts | 1 | 1 | 9 | 9 |
Avg. Estimate | 23.8 | 22.7 | 82.79 | 99.28 |
Low Estimate | 23.8 | 22.7 | 65.2 | 79.7 |
High Estimate | 23.8 | 22.7 | 96.6 | 116.4 |
Year Ago EPS | N/A | N/A | N/A | 82.79 |
Revenue Estimate | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|
No. of Analysts | 2 | 2 | 8 | 8 |
Avg. Estimate | 7.97B | 8.31B | 32.82B | 37.17B |
Low Estimate | 7.68B | 8.29B | 31.87B | 35.55B |
High Estimate | 8.25B | 8.33B | 34B | 39.17B |
Year Ago Sales | N/A | N/A | N/A | 32.82B |
Sales Growth (year/est) | N/A | N/A | N/A | 13.30% |
Earnings History | Invalid Date | Invalid Date | Invalid Date | 6/30/2021 |
---|
EPS Est. | N/A | N/A | N/A | 19.6 |
EPS Actual | N/A | N/A | N/A | 20.08 |
Difference | N/A | N/A | N/A | 0.48 |
Surprise % | N/A | N/A | N/A | 2.40% |
EPS Trend | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|
Current Estimate | 23.8 | 22.7 | 82.79 | 99.28 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions | Current Qtr. (Sep 2021) | Next Qtr. (Dec 2021) | Current Year (2022) | Next Year (2023) |
---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | N/A |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | AJANTPHARM.NS | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | N/A | N/A | N/A | N/A |
Next Qtr. | N/A | N/A | N/A | N/A |
Current Year | N/A | N/A | N/A | N/A |
Next Year | 19.90% | N/A | N/A | N/A |
Next 5 Years (per annum) | -14.50% | N/A | N/A | N/A |
Past 5 Years (per annum) | 11.83% | N/A | N/A | N/A |